Aktie A1C9MC MARIZYME, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Marizyme, Inc. Other OTC

Aktien

A1C9MC

US5703721028

GBSX

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Marizyme Enters Into Co-Development Agreement With Qualigen Therapeutics for the Commercialization of FDA-Cleared DuraGraft™
Marizyme, Inc. Announces Resignation of Julie Kampf from the Board of Directors
Marizyme, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Marizyme CEO Delivers Business Update
Marizyme CEO Delivers Business Update
OTC Active Stocks Watchlist (EPAZ, MRZM, GCEI, TMGI)
Marizyme, Inc. Announces FDA Clearance for Flagship Product, DuraGraft™
Marizyme, Inc. Announces FDA Clearance for Product, Duragraft
Marizyme, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
MARIZYME, INC. : Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
Marizyme, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Marizyme, Inc. announced a financing transaction
MARIZYME INC : Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
Marizyme Announces IP Developments for DuraGraft® and Its Pipeline Products
Marizyme Announces IP Developments for DuraGraft® and Its Pipeline Products
Marizyme, Inc. Announces IP Developments for DuraGraft and its Pipeline of Products
Marizyme, Inc. announced that it has received $0.265216 million in funding
Marizyme CEO Delivers Business Update
MARIZYME INC Submission of Matters to a Vote of Security Holders (form 8-K/A)
MARIZYME INC : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2JRNL Aktie
  4. A1C9MC Aktie
  5. Nachrichten Marizyme, Inc.
  6. Andere Sprachen